Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2012

Open Access 01-12-2012 | Original investigation

Low serum magnesium concentrations are associated with a high prevalence of premature ventricular complexes in obese adults with type 2 diabetes

Authors: Liana C Del Gobbo, Yiqing Song, Paul Poirier, Eric Dewailly, Ronald J Elin, Grace M Egeland

Published in: Cardiovascular Diabetology | Issue 1/2012

Login to get access

Abstract

Background

Premature ventricular complexes (PVC) predict cardiovascular mortality among several adult populations. Increased arrhythmia prevalence has been reported during controlled magnesium (Mg) depletion studies in adults. We thus hypothesized that serum magnesium (sMg) concentrations are inversely associated with the prevalence of PVC in adults at high cardiovascular risk.

Methods

Anthropometric, demographic and lifestyle characteristics were assessed in 750 Cree adults, aged > 18 yrs, who participated in an age-stratified, cross-sectional health survey in Quebec, Canada. Holter electrocardiograms recorded heart rate variability and cardiac arrhythmias for two consecutive hours. Multivariate logistic regression was used to evaluate the associations between sMg and PVC.

Results

PVC prevalence in adults with hypomagnesemia (sMg ≤ 0.70 mmol/L) was more than twice that of adults without hypomagnesemia (50% vs. 21%, p = 0.015); results were similar when adults with cardiovascular disease history were excluded. All hypomagnesemic adults with PVC had type 2 diabetes (T2DM). Prevalence of PVC declined across the sMg concentration gradient in adults with T2DM only (p < 0.001 for linear trend). In multivariate logistic regressions adjusted for age, sex, community, body mass index, smoking, physical activity, alcohol consumption, kidney disease, antihypertensive and cholesterol lowering drug use, and blood docosahexaenoic acid concentrations, the odds ratio of PVC among T2DM subjects with sMg > 0.70 mmol/L was 0.24 (95% CI: 0.06-0.98) p = 0.046 compared to those with sMg ≤ 0.70 mmol/L.

Conclusions

sMg concentrations were inversely associated with the prevalence of PVC in patients with T2DM in a dose response manner, indicating that suboptimal sMg may be a contributor to arrhythmias among patients with T2DM.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kennedy HL, Whitlock JA, Sprague MK, Kennedy LJ, Buckingham TA, Goldberg RJ: Long-term follow-up of asymptomatic healthy subjects with frequent and complex ventricular ectopy. N Engl J Med. 1985, 312: 193-197. 10.1056/NEJM198501243120401.CrossRefPubMed Kennedy HL, Whitlock JA, Sprague MK, Kennedy LJ, Buckingham TA, Goldberg RJ: Long-term follow-up of asymptomatic healthy subjects with frequent and complex ventricular ectopy. N Engl J Med. 1985, 312: 193-197. 10.1056/NEJM198501243120401.CrossRefPubMed
2.
go back to reference Gaita F, Giustetto C, Di Donna P, Richiardi E, Libero L, Rosa MC, Molinari G, Trevi G: Long-term follow-up of right ventricular monomorphic extrasystoles. J Am Coll Cardiol. 2001, 38: 364-370. 10.1016/S0735-1097(01)01403-6.CrossRefPubMed Gaita F, Giustetto C, Di Donna P, Richiardi E, Libero L, Rosa MC, Molinari G, Trevi G: Long-term follow-up of right ventricular monomorphic extrasystoles. J Am Coll Cardiol. 2001, 38: 364-370. 10.1016/S0735-1097(01)01403-6.CrossRefPubMed
3.
go back to reference Sajadieh A, Nielsen OW, Rasmussen V, Hein HO, Frederiksen BS, Davanlou M, Hansen JF: Ventricular arrhythmias and risk of death and acute myocardial infarction in apparently healthy subjects of age > = 55 years. Am J Cardiol. 2006, 97: 1351-1357. 10.1016/j.amjcard.2005.11.067.CrossRefPubMed Sajadieh A, Nielsen OW, Rasmussen V, Hein HO, Frederiksen BS, Davanlou M, Hansen JF: Ventricular arrhythmias and risk of death and acute myocardial infarction in apparently healthy subjects of age > = 55 years. Am J Cardiol. 2006, 97: 1351-1357. 10.1016/j.amjcard.2005.11.067.CrossRefPubMed
4.
go back to reference Cheriyath P, He F, Peters I, Li XA, Alagona P, Wu CT, Pu M, Cascio WE, Liao DP: Relation of atrial and/or ventricular premature complexes on a two-minute rhythm strip to the risk of sudden cardiac death (the atherosclerosis risk in communities [ARIC] study. Am J Cardiol. 2011, 107: 151-155. 10.1016/j.amjcard.2010.09.002.CrossRefPubMed Cheriyath P, He F, Peters I, Li XA, Alagona P, Wu CT, Pu M, Cascio WE, Liao DP: Relation of atrial and/or ventricular premature complexes on a two-minute rhythm strip to the risk of sudden cardiac death (the atherosclerosis risk in communities [ARIC] study. Am J Cardiol. 2011, 107: 151-155. 10.1016/j.amjcard.2010.09.002.CrossRefPubMed
5.
go back to reference Stein PK, Sanghavi D, Sotoodehnia N, Siscovick DS, Gottdiener J: Association of Holter-based measures including T-wave altemans with risk of sudden cardiac death in the community-dwelling elderly: the cardiovascular health study. J Electrocardiol. 2010, 43: 251-259. 10.1016/j.jelectrocard.2009.12.009.PubMedCentralCrossRefPubMed Stein PK, Sanghavi D, Sotoodehnia N, Siscovick DS, Gottdiener J: Association of Holter-based measures including T-wave altemans with risk of sudden cardiac death in the community-dwelling elderly: the cardiovascular health study. J Electrocardiol. 2010, 43: 251-259. 10.1016/j.jelectrocard.2009.12.009.PubMedCentralCrossRefPubMed
6.
go back to reference Abdalla ISH, Prineas RJ, Neaton JD, Jacobs DR, Crow RS: Relation between ventricular premature complexes and sudden cardiac death in apparently healthy men. Am J Cardiol. 1987, 60: 1036-1042. 10.1016/0002-9149(87)90348-1.CrossRefPubMed Abdalla ISH, Prineas RJ, Neaton JD, Jacobs DR, Crow RS: Relation between ventricular premature complexes and sudden cardiac death in apparently healthy men. Am J Cardiol. 1987, 60: 1036-1042. 10.1016/0002-9149(87)90348-1.CrossRefPubMed
7.
go back to reference Raiha IJ, Piha SJ, Seppanen A, Puukka P, Sourander L: Predictive value of continuous ambulatory electrocardiographic monitoring in elderly people. Br Med J. 1994, 309: 1263-1267. 10.1136/bmj.309.6964.1263.CrossRef Raiha IJ, Piha SJ, Seppanen A, Puukka P, Sourander L: Predictive value of continuous ambulatory electrocardiographic monitoring in elderly people. Br Med J. 1994, 309: 1263-1267. 10.1136/bmj.309.6964.1263.CrossRef
8.
go back to reference Fawcett WJ, Haxby EJ, Male DA: Magnesium: physiology and pharmacology. Br J Anaesth. 1999, 83: 302-320.CrossRefPubMed Fawcett WJ, Haxby EJ, Male DA: Magnesium: physiology and pharmacology. Br J Anaesth. 1999, 83: 302-320.CrossRefPubMed
9.
go back to reference Abbot LG, Rude RK: Clinical manifestations of magnesium deficiency. Miner Electrolyte Metab. 1993, 19: 314-322. Abbot LG, Rude RK: Clinical manifestations of magnesium deficiency. Miner Electrolyte Metab. 1993, 19: 314-322.
10.
go back to reference Parikka H, Toivonen L, Naukkarinen V, Tierala I, Pohjola-Sintonen S, Heikkila J, Nieminen MS: Decreases by magnesium of QT dispersion and ventricular arrhythmias in patients with acute myocardial infarction. Eur Heart J. 1999, 20: 111-120. 10.1053/euhj.1998.1238.CrossRefPubMed Parikka H, Toivonen L, Naukkarinen V, Tierala I, Pohjola-Sintonen S, Heikkila J, Nieminen MS: Decreases by magnesium of QT dispersion and ventricular arrhythmias in patients with acute myocardial infarction. Eur Heart J. 1999, 20: 111-120. 10.1053/euhj.1998.1238.CrossRefPubMed
11.
go back to reference Chakraborti S, Chakraborti T, Mandal M, Mandal A, Das S, Ghosh S: Protective role of magnesium in cardiovascular diseases: a review. Mol Cell Biochem. 2002, 238: 163-179. 10.1023/A:1019998702946.CrossRefPubMed Chakraborti S, Chakraborti T, Mandal M, Mandal A, Das S, Ghosh S: Protective role of magnesium in cardiovascular diseases: a review. Mol Cell Biochem. 2002, 238: 163-179. 10.1023/A:1019998702946.CrossRefPubMed
12.
go back to reference Nielsen FH, Milne DB, Klevay LM, Gallagher S, Johnson L: Dietary magnesium deficiency induces heart rhythm changes, impairs glucose tolerance, and decreases serum cholesterol in post menopausal women. J Am Coll Nutr. 2007, 26: 121-132.CrossRefPubMed Nielsen FH, Milne DB, Klevay LM, Gallagher S, Johnson L: Dietary magnesium deficiency induces heart rhythm changes, impairs glucose tolerance, and decreases serum cholesterol in post menopausal women. J Am Coll Nutr. 2007, 26: 121-132.CrossRefPubMed
13.
go back to reference Klevay LM, Milne DB: Low dietary magnesium increases supraventricular ectopy. Am J Clin Nutr. 2002, 75: 550-554.PubMed Klevay LM, Milne DB: Low dietary magnesium increases supraventricular ectopy. Am J Clin Nutr. 2002, 75: 550-554.PubMed
14.
go back to reference Tsuji H, Venditti FJ, Evans JC, Larson MG, Levy D: The associations of levels of serum potassium and magnesium with ventricular premature complexes (The Framingham heart study). Am J Cardiol. 1994, 74: 232-235. 10.1016/0002-9149(94)90362-X.CrossRefPubMed Tsuji H, Venditti FJ, Evans JC, Larson MG, Levy D: The associations of levels of serum potassium and magnesium with ventricular premature complexes (The Framingham heart study). Am J Cardiol. 1994, 74: 232-235. 10.1016/0002-9149(94)90362-X.CrossRefPubMed
15.
go back to reference Rude RK, Shils ME: Magnesium. Modern Nutrition in Health and Disease. Edited by: Shils ME, Shike M, Ross AC, Caballero B, Cousins RJ. 2006, New York: Lippincott Williams & Wilkins, 234-10 Rude RK, Shils ME: Magnesium. Modern Nutrition in Health and Disease. Edited by: Shils ME, Shike M, Ross AC, Caballero B, Cousins RJ. 2006, New York: Lippincott Williams & Wilkins, 234-10
16.
go back to reference Escobedo LG, Caspersen CJ: Risk factors for sudden coronary death in the United States. Epidemiol. 1997, 8: 175-180. 10.1097/00001648-199703000-00009.CrossRef Escobedo LG, Caspersen CJ: Risk factors for sudden coronary death in the United States. Epidemiol. 1997, 8: 175-180. 10.1097/00001648-199703000-00009.CrossRef
18.
go back to reference Harris SB, Gittelsohn J, Hanley A, Barnie A, Wolever TM, Gao XJ, Logan A, Zinman B: The prevalence of NIDDM and associated risk factors in native Canadians. Diabetes Care. 1997, 20: 185-187. 10.2337/diacare.20.2.185.CrossRefPubMed Harris SB, Gittelsohn J, Hanley A, Barnie A, Wolever TM, Gao XJ, Logan A, Zinman B: The prevalence of NIDDM and associated risk factors in native Canadians. Diabetes Care. 1997, 20: 185-187. 10.2337/diacare.20.2.185.CrossRefPubMed
19.
go back to reference Egeland GM, Denomme D, Lejeune P, Pereg D: Concurrent validity of the international physical activity questionnaire (IPAQ) in an Iiyiyiu Aschii (Cree) community. Can J Pub Health. 2008, 99: 307-310. Egeland GM, Denomme D, Lejeune P, Pereg D: Concurrent validity of the international physical activity questionnaire (IPAQ) in an Iiyiyiu Aschii (Cree) community. Can J Pub Health. 2008, 99: 307-310.
20.
go back to reference Russo GL: Dietary n-6 and n-3 polyunsaturated fatty acids: from biochemistry to clinical implications in cardiovascular prevention. Biochem Pharmacol. 2009, 77: 937-946. 10.1016/j.bcp.2008.10.020.CrossRefPubMed Russo GL: Dietary n-6 and n-3 polyunsaturated fatty acids: from biochemistry to clinical implications in cardiovascular prevention. Biochem Pharmacol. 2009, 77: 937-946. 10.1016/j.bcp.2008.10.020.CrossRefPubMed
21.
go back to reference Mozaffarian D, Psaty BM, Rimm EB, Lemaitre RN, Burke GL, Lyles MF, Lefkowitz D, Siscovick DS: Fish intake and risk of incident atrial fibrillation. Circulation. 2004, 110: 368-373. 10.1161/01.CIR.0000138154.00779.A5.PubMedCentralCrossRefPubMed Mozaffarian D, Psaty BM, Rimm EB, Lemaitre RN, Burke GL, Lyles MF, Lefkowitz D, Siscovick DS: Fish intake and risk of incident atrial fibrillation. Circulation. 2004, 110: 368-373. 10.1161/01.CIR.0000138154.00779.A5.PubMedCentralCrossRefPubMed
22.
go back to reference Alberti KGMM, Ecklel RH, Grundy SM, IDF Epidemiology Task Force Consensus Group: Harmonizing the metabolic syndrome. Circulation. 2009, 120: 1640-1645. 10.1161/CIRCULATIONAHA.109.192644.CrossRefPubMed Alberti KGMM, Ecklel RH, Grundy SM, IDF Epidemiology Task Force Consensus Group: Harmonizing the metabolic syndrome. Circulation. 2009, 120: 1640-1645. 10.1161/CIRCULATIONAHA.109.192644.CrossRefPubMed
23.
go back to reference Stein PK, Barzilay JI, Chaves PHM, Mistretta SQ, Domitrovich PP, Gottdiener JS, Rich MW, Kleiger RE: Novel measures of heart rate variability predict cardiovascular mortality in older adults independent of traditional cardiovascular risk factors: the cardiovascular health study (CHS). J Cardio Electrophysiol. 2008, 19: 1169-1174. 10.1111/j.1540-8167.2008.01232.x.CrossRef Stein PK, Barzilay JI, Chaves PHM, Mistretta SQ, Domitrovich PP, Gottdiener JS, Rich MW, Kleiger RE: Novel measures of heart rate variability predict cardiovascular mortality in older adults independent of traditional cardiovascular risk factors: the cardiovascular health study (CHS). J Cardio Electrophysiol. 2008, 19: 1169-1174. 10.1111/j.1540-8167.2008.01232.x.CrossRef
24.
go back to reference Alghamdi SMG, Cameron EC, Sutton RAL: Magnesium deficiency: pathophysiologic and clinical overview. Am J Kidney Dis. 1994, 24: 737-752.CrossRef Alghamdi SMG, Cameron EC, Sutton RAL: Magnesium deficiency: pathophysiologic and clinical overview. Am J Kidney Dis. 1994, 24: 737-752.CrossRef
25.
go back to reference Loeb HS, Pietras RJ, Gunnar RM, Tobin JR: Paroxysmal ventricular fibrillation in two patients with hypomagnesemia. Circulation. 1968, 3: 210-215.CrossRef Loeb HS, Pietras RJ, Gunnar RM, Tobin JR: Paroxysmal ventricular fibrillation in two patients with hypomagnesemia. Circulation. 1968, 3: 210-215.CrossRef
26.
go back to reference Dyckner T, Wester PO: Magnesium deficiency contributing to ventricular tachycardia. Acta Med Scand. 1982, 212: 89-91.CrossRefPubMed Dyckner T, Wester PO: Magnesium deficiency contributing to ventricular tachycardia. Acta Med Scand. 1982, 212: 89-91.CrossRefPubMed
27.
go back to reference Ramme SP, White CJ, Svinarich JT, Watson TD, Fox RF: Torsade de pointes and magnesium deficiency. Am Heart J. 1985, 109: 89-91. Ramme SP, White CJ, Svinarich JT, Watson TD, Fox RF: Torsade de pointes and magnesium deficiency. Am Heart J. 1985, 109: 89-91.
28.
go back to reference Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Smith SC, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B, Blanc JJ, Budaj A, Dean V, Deckers JW, et al: ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of cardiology/American heart association task force and the European Society of cardiology committee for practice guidelines (Writing committee to develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death). J Am Coll Cardiol. 2006, 48: e247-e346. 10.1016/j.jacc.2006.07.010.CrossRefPubMed Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Smith SC, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B, Blanc JJ, Budaj A, Dean V, Deckers JW, et al: ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of cardiology/American heart association task force and the European Society of cardiology committee for practice guidelines (Writing committee to develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death). J Am Coll Cardiol. 2006, 48: e247-e346. 10.1016/j.jacc.2006.07.010.CrossRefPubMed
29.
go back to reference Belardinelli L, Antzelevitch C, Vos MA: Assessing predictors of drug-induced torsade de pointes. Trends Pharmacol Sci. 2003, 24: 619-625. 10.1016/j.tips.2003.10.002.CrossRefPubMed Belardinelli L, Antzelevitch C, Vos MA: Assessing predictors of drug-induced torsade de pointes. Trends Pharmacol Sci. 2003, 24: 619-625. 10.1016/j.tips.2003.10.002.CrossRefPubMed
30.
go back to reference Millante TA, Ward DE, Camm AJ: Is hypomagnesemia arrhythmogenic?. Clin Cardiol. 1992, 15: 103-108. 10.1002/clc.4960150210.CrossRef Millante TA, Ward DE, Camm AJ: Is hypomagnesemia arrhythmogenic?. Clin Cardiol. 1992, 15: 103-108. 10.1002/clc.4960150210.CrossRef
31.
go back to reference Mubagwa K, Gwanyanya A, Zakharov S, Macianskiene R: Regulation of cation channels in cardiac and smooth muscle cells by intracellular magnesium. Arch Biochem Biophys. 2007, 458: 73-89. 10.1016/j.abb.2006.10.014.CrossRefPubMed Mubagwa K, Gwanyanya A, Zakharov S, Macianskiene R: Regulation of cation channels in cardiac and smooth muscle cells by intracellular magnesium. Arch Biochem Biophys. 2007, 458: 73-89. 10.1016/j.abb.2006.10.014.CrossRefPubMed
32.
33.
go back to reference Saran T, Perkins JD, Javed MA: Does the prophylactic administration of magnesium sulphate to patients undergoing thoracotomy prevent postoperative supraventricular arrhythmias? A randomized controlled trial. Br J Anaesth. 2011, 106: 785-791. 10.1093/bja/aer096.CrossRefPubMed Saran T, Perkins JD, Javed MA: Does the prophylactic administration of magnesium sulphate to patients undergoing thoracotomy prevent postoperative supraventricular arrhythmias? A randomized controlled trial. Br J Anaesth. 2011, 106: 785-791. 10.1093/bja/aer096.CrossRefPubMed
34.
go back to reference Håglin L, Backman L, Tornkvist BL: A structural equation model for assessment of links between changes in serum triglycerides, -urate, and -glucose and changes in serum calcium, -magnesium and -phosphate in type 2 diabetes and non-diabetes metabolism. Cardiovasc Diabetol. 2011, 10: 116-10.1186/1475-2840-10-116.PubMedCentralCrossRefPubMed Håglin L, Backman L, Tornkvist BL: A structural equation model for assessment of links between changes in serum triglycerides, -urate, and -glucose and changes in serum calcium, -magnesium and -phosphate in type 2 diabetes and non-diabetes metabolism. Cardiovasc Diabetol. 2011, 10: 116-10.1186/1475-2840-10-116.PubMedCentralCrossRefPubMed
35.
go back to reference Simmons D, Joshi S, Shaw J: Hypomagnesaemia is associated with diabetes: not pre-diabetes, obesity or the metabolic syndrome. Diabetes Res Clin Pract. 2010, 87: 261-266. 10.1016/j.diabres.2009.11.003.CrossRefPubMed Simmons D, Joshi S, Shaw J: Hypomagnesaemia is associated with diabetes: not pre-diabetes, obesity or the metabolic syndrome. Diabetes Res Clin Pract. 2010, 87: 261-266. 10.1016/j.diabres.2009.11.003.CrossRefPubMed
36.
go back to reference Røislien J, Van Calster B, Hjelmesæth J: Parathyroid hormone is a plausible mediator for the metabolic syndrome in the morbidly obese: a cross-sectional study. Cardiovasc Diabetol. 2011, 10: 17-10.1186/1475-2840-10-17.PubMedCentralCrossRefPubMed Røislien J, Van Calster B, Hjelmesæth J: Parathyroid hormone is a plausible mediator for the metabolic syndrome in the morbidly obese: a cross-sectional study. Cardiovasc Diabetol. 2011, 10: 17-10.1186/1475-2840-10-17.PubMedCentralCrossRefPubMed
37.
go back to reference Kalaitzidis R, Tismihodimos V, Bairaktari E, Siamopoulos K, Elisaf M: Disturbances of phosphate metabolism: another feature of the metabolic syndrome. J Kidney Dis. 2005, 45: 851-858. 10.1053/j.ajkd.2005.01.005.CrossRef Kalaitzidis R, Tismihodimos V, Bairaktari E, Siamopoulos K, Elisaf M: Disturbances of phosphate metabolism: another feature of the metabolic syndrome. J Kidney Dis. 2005, 45: 851-858. 10.1053/j.ajkd.2005.01.005.CrossRef
38.
go back to reference de Valk HW: Magnesium in diabetes mellitus. Neth J Med. 1999, 54: 139-146. 10.1016/S0300-2977(99)00005-4.CrossRefPubMed de Valk HW: Magnesium in diabetes mellitus. Neth J Med. 1999, 54: 139-146. 10.1016/S0300-2977(99)00005-4.CrossRefPubMed
39.
go back to reference Peacock JM, Ohira T, Post W, Sotoodehnia N, Rosamond W, Folson AR: Serum magnesium and risk of sudden cardiac death in the atherosclerosis risk in communities (aric) study. Am Heart J. 2010, 160: 464-470. 10.1016/j.ahj.2010.06.012.PubMedCentralCrossRefPubMed Peacock JM, Ohira T, Post W, Sotoodehnia N, Rosamond W, Folson AR: Serum magnesium and risk of sudden cardiac death in the atherosclerosis risk in communities (aric) study. Am Heart J. 2010, 160: 464-470. 10.1016/j.ahj.2010.06.012.PubMedCentralCrossRefPubMed
40.
go back to reference Reffelmann T, Ittermann T, Dörr M, Völzke H, Reinthaler M, Petersmann A, Felix SB: Low serum magnesium concentrations predict cardiovascular and all-cause mortality. Atherosclerosis. 2011, 219: 280-284. 10.1016/j.atherosclerosis.2011.05.038.CrossRefPubMed Reffelmann T, Ittermann T, Dörr M, Völzke H, Reinthaler M, Petersmann A, Felix SB: Low serum magnesium concentrations predict cardiovascular and all-cause mortality. Atherosclerosis. 2011, 219: 280-284. 10.1016/j.atherosclerosis.2011.05.038.CrossRefPubMed
41.
go back to reference Ford ES: Serum magnesium and ischaemic heart disease: findings from a national sample of US adults. Int J Epidemiol. 1999, 28: 645-651. 10.1093/ije/28.4.645.CrossRefPubMed Ford ES: Serum magnesium and ischaemic heart disease: findings from a national sample of US adults. Int J Epidemiol. 1999, 28: 645-651. 10.1093/ije/28.4.645.CrossRefPubMed
42.
go back to reference Barbagallo M, Dominguez LJ: Magnesium metabolism in type 2 diabetes mellitus, metabolic syndrome and insulin resistance. Arch Biochem Biophys. 2007, 458: 40-47. 10.1016/j.abb.2006.05.007.CrossRefPubMed Barbagallo M, Dominguez LJ: Magnesium metabolism in type 2 diabetes mellitus, metabolic syndrome and insulin resistance. Arch Biochem Biophys. 2007, 458: 40-47. 10.1016/j.abb.2006.05.007.CrossRefPubMed
Metadata
Title
Low serum magnesium concentrations are associated with a high prevalence of premature ventricular complexes in obese adults with type 2 diabetes
Authors
Liana C Del Gobbo
Yiqing Song
Paul Poirier
Eric Dewailly
Ronald J Elin
Grace M Egeland
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2012
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/1475-2840-11-23

Other articles of this Issue 1/2012

Cardiovascular Diabetology 1/2012 Go to the issue